BOSTON – Dec. 6, 2022 – Jacqueline T. deGrandpre, litigation shareholder in global law firm Greenberg Traurig, LLP’s Boston office and co-chair of the Boston Bar Association (BBA) Products Liability Section, is leading a BBA panel Dec. 15. The panel, which includes Sabrina R. Gallo, a shareholder in the firm’s Miami office, will focus on the use of social media in products liability cases and will feature panelists from both the plaintiff and defense perspective. deGrandpre will moderate the panel, and speakers will provide insight and guidance for counseling clients on social media and how it relates to their case. To learn more and register, click here.
deGrandpre focuses her practice on products liability litigation with an emphasis on pharmaceutical, medical devices, and other consumer products. She also focuses on general litigation matters including commercial litigation, complex business disputes, eminent domain, and white collar criminal matters. deGrandpre has experience representing clients responding to civil investigative demands and enforcement actions brought by both federal and state regulatory agencies. Among other things, she has experience in defending companies against unfair or deceptive business practices claims, like Massachusetts General Laws Chapter 93A - Massachusetts Consumer Protection Act. In addition, she regularly advises and trains clients on information governance, eDiscovery, data privacy issues, cyber security, and litigation preparedness.
Gallo is chair of the Miami Products Liability & Mass Torts Practice and a shareholder in the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice. She concentrates her practice on the representation and defense of products liability cases, with an emphasis on representing manufacturers of medical devices and pharmaceuticals in state and federal courts nationwide. Gallo has experience managing individual, nationwide, and mass tort litigation involving a variety of medical devices including infusion and insulin pumps, mesh, vascular products, and other medical devices and implants, as well as pharmaceuticals including chemotherapy medications and hormone replacement therapy.